Association of high-sensitivity cardiac troponin T with all-cause and cardiovascular mortality in older adults with low lean mass: A 14.6-year longitudinal study.
暂无分享,去创建一个
Xu Zhu | Xin Yue | S. Liao | W. Yao | Yan-li Zhou | Xinli Li | Haifeng Zhang | Q. Qu | Rongrong Gao | Qixin Guo | Ziqi Chen | Jinjing Shi | I. Cheang | Jinyu Sun | Yanping Shi | Lu Chen
[1] A. Jaffe,et al. High-Sensitivity Cardiac Troponin T Elevation in Hypertrophic Cardiomyopathy Is Associated With Ventricular Arrhythmias. , 2023, Mayo Clinic proceedings.
[2] S. Larsson,et al. Epidemiology of sarcopenia: Prevalence, risk factors, and consequences. , 2023, Metabolism: clinical and experimental.
[3] Shanshan Shi,et al. Nutrition-related diseases and cardiovascular mortality in American society: national health and nutrition examination study, 1999–2006 , 2022, BMC Public Health.
[4] G. Filippatos,et al. Prognostic Implications of N-terminal Pro-B Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T in EMPEROR-Preserved. , 2022, JACC. Heart failure.
[5] M. Emdin,et al. High-sensitivity troponins for outcome prediction in the general population: a systematic review and meta-analysis. , 2022, European journal of internal medicine.
[6] Nana He,et al. Relationship Between Sarcopenia and Cardiovascular Diseases in the Elderly: An Overview , 2021, Frontiers in Cardiovascular Medicine.
[7] C. Celis-Morales,et al. Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis , 2021, Journal of cachexia, sarcopenia and muscle.
[8] K. Stark,et al. Distribution and specificity of high-sensitivity cardiac troponin T in older adults without acute cardiac conditions: cross-sectional results from the population-based AugUR study , 2021, BMJ Open.
[9] M. Bilodeau,et al. How do we define and measure sarcopenia? A meta-analysis of observational studies. , 2021, Age and Ageing.
[10] M. N. Kim,et al. Risk stratification using sarcopenia status among subjects with metabolic dysfunction‐associated fatty liver disease , 2021, Journal of cachexia, sarcopenia and muscle.
[11] T. Karlsen,et al. Exercise training and high‐sensitivity cardiac troponin T in patients with heart failure with reduced ejection fraction , 2021, ESC heart failure.
[12] Xin Gao,et al. Sarcopenia, sarcopenic overweight/obesity and risk of cardiovascular disease and cardiac arrhythmia: A cross-sectional study. , 2020, Clinical nutrition.
[13] A. Tveit,et al. Cardiac Troponin I and T Are Associated with Left Ventricular Function and Structure: Data from the Akershus Cardiac Examination 1950 Study. , 2020, Clinical chemistry.
[14] E. Kang,et al. Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk. , 2020, The American journal of gastroenterology.
[15] G. Dagenais,et al. Variability in High-Sensitivity Cardiac Troponin T Testing in Stable Patients With and Without Coronary Artery Disease. , 2019, The Canadian journal of cardiology.
[16] C. Pinho,et al. Sarcopenia and sarcopenic obesity as prognostic predictors in hospitalized elderly patients with acute myocardial infarction , 2019, Einstein.
[17] Kristina Norman,et al. Financial impact of sarcopenia or low muscle mass - A short review. , 2019, Clinical nutrition.
[18] Y. Morino,et al. Association between high-sensitivity cardiac troponin T and future cardiovascular incidence in a general Japanese population: results from the Tohoku medical megabank project , 2019, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[19] A. Sayer,et al. Sarcopenia , 2019, The Lancet.
[20] M. Woodward,et al. Cardiac Troponin T and Troponin I in the General Population , 2019, Circulation.
[21] Tamas Fulop,et al. Increased level of high-sensitivity cardiac Troponin T in a geriatric population is determined by comorbidities compared to age , 2019, International journal of cardiology. Heart & vasculature.
[22] Wei Wu,et al. Comparison of prognostic values of high-sensitivity cardiac troponin T and N-terminal prohormone brain natriuretic peptide to assess mortality in elderly inpatients , 2018, Clinical interventions in aging.
[23] M. Woodward,et al. Comparison between High-Sensitivity Cardiac Troponin T and Cardiac Troponin I in a Large General Population Cohort. , 2018, Clinical chemistry.
[24] Kristian Thygesen,et al. Fourth Universal Definition of Myocardial Infarction (2018). , 2018, Journal of the American College of Cardiology.
[25] S. Kirkpatrick,et al. Update of the Healthy Eating Index: HEI-2015. , 2018, Journal of the Academy of Nutrition and Dietetics.
[26] G. Lip,et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. , 2018, European heart journal.
[27] A. Jaffe,et al. Possible mechanisms behind cardiac troponin elevations , 2018, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[28] S. Torii,et al. Lean Soft Tissue Mass Measured Using Dual-Energy X-Ray Absorptiometry Is an Effective Index for Assessing Change in Leg Skeletal Muscle Mass Following Exercise Training. , 2018, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.
[29] Wei Wu,et al. Relationship between high-sensitivity cardiac troponin T and the prognosis of elderly inpatients with non-acute coronary syndromes , 2018, Clinical interventions in aging.
[30] Johannes Schmid,et al. Elevated Cardiac Troponin T in Patients With Skeletal Myopathies. , 2018, Journal of the American College of Cardiology.
[31] D. Monneret,et al. Determination of age- and sex-specific 99th percentiles for high-sensitive troponin T from patients: an analytical imprecision- and partitioning-based approach , 2017, Clinical chemistry and laboratory medicine.
[32] N. Sattar,et al. High-Sensitivity Cardiac Troponin Concentration and Risk of First-Ever Cardiovascular Outcomes in 154,052 Participants , 2017, Journal of the American College of Cardiology.
[33] M. Zeegers,et al. Prognostic value of basal high-sensitive cardiac troponin levels on mortality in the general population , 2016, Medicine.
[34] G. Schaaf,et al. Elevated Plasma Cardiac Troponin T Levels Caused by Skeletal Muscle Damage in Pompe Disease , 2016, Circulation. Cardiovascular genetics.
[35] H. Brunner-La Rocca,et al. Clinical Interpretation of Elevated Concentrations of Cardiac Troponin T, but Not Troponin I, in Nursing Home Residents. , 2015, Journal of the American Medical Directors Association.
[36] L. Geiss,et al. Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012. , 2015, JAMA.
[37] K. Kamiya,et al. Frailty may be a risk marker for adverse outcome in patients with congestive heart failure , 2015, ESC heart failure.
[38] S. Seliger,et al. Use and interpretation of high sensitivity cardiac troponins in patients with chronic kidney disease with and without acute myocardial infarction. , 2015, Clinical biochemistry.
[39] Robert H Christenson,et al. Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay. , 2014, Journal of the American College of Cardiology.
[40] K. Lewandrowski,et al. Measurement of high-sensitivity troponin T in noncardiac medical intensive care unit patients. Correlation to mortality and length of stay. , 2014, American journal of clinical pathology.
[41] Maren S Fragala,et al. The FNIH Sarcopenia Project: Rationale, Study Description, Conference Recommendations, and Final Estimates , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.
[42] A. Go,et al. Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC) , 2013, BMC Nephrology.
[43] Lester R Curtin,et al. National health and nutrition examination survey: analytic guidelines, 1999-2010. , 2013, Vital and health statistics. Series 2, Data evaluation and methods research.
[44] A. Khera,et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. , 2010, JAMA.
[45] T. Kawada,et al. Association between high-sensitivity cardiac troponin T levels and the predicted cardiovascular risk in middle-aged men without overt cardiovascular disease. , 2010, American heart journal.
[46] A. Jaffe,et al. Analytical validation of a high-sensitivity cardiac troponin T assay. , 2010, Clinical chemistry.
[47] C. Schmid,et al. A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.
[48] L. Lind,et al. Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects. , 2008, European heart journal.
[49] B. Kligler. Ask the experts: Is there any real evidence that people who eat organic food are healthier? , 2007, Explore.
[50] S. Pocock,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, The Lancet.
[51] A. Torbicki,et al. Cardiac troponin T monitoring identifies high-risk group of normotensive patients with acute pulmonary embolism. , 2003, Chest.
[52] S. Heymsfield,et al. Total-body skeletal muscle mass: estimation by a new dual-energy X-ray absorptiometry method. , 2002, The American journal of clinical nutrition.
[53] S Greenland,et al. Avoiding power loss associated with categorization and ordinal scores in dose-response and trend analysis. , 1995, Epidemiology.
[54] P. Grambsch,et al. Proportional hazards tests and diagnostics based on weighted residuals , 1994 .
[55] S. Grundy,et al. National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .
[56] G. Braemer. International statistical classification of diseases and related health problems. Tenth revision. , 1988, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.